Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-18-005403
Filing Date
2018-08-03
Accepted
2018-08-03 16:59:56
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B5 a2236402z424b5.htm 424B5 785194
2 G413503.JPG g413503.jpg GRAPHIC 15691
3 G213688.JPG g213688.jpg GRAPHIC 1340
4 G393885.JPG g393885.jpg GRAPHIC 14542
5 G340219.JPG g340219.jpg GRAPHIC 1330
6 G867892.JPG g867892.jpg GRAPHIC 148374
7 G788960.JPG g788960.jpg GRAPHIC 21824
  Complete submission text file 0001047469-18-005403.txt   1066860
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-218301 | Film No.: 18992627
SIC: 2834 Pharmaceutical Preparations